GlassScriptPhysician profile
Anne Elizabeth Kenney
NPI 1184722852
$2,429.06
in general payments reported to CMS, 2019-2025
28 companies · $240 in 2025
The $240 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $950 · 2022: $592 · 2023: $574 · 2024: $73.19 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $887.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $617.42 | 2021-2024 | |
| Novo Nordisk INC | $469.98 | 2021-2023 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $289.09 | 2021-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Tactile Systems Technology INC | $191.32 | 2025 | Nimbl, Flexitouch Plus |
| Lilly USA, LLC | $165.34 | 2021-2023 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.77 | 2021-2024 | Ofev |
| Biohaven Pharmaceutical Holding Company LTD. | $75.13 | 2022 | |
| Pfizer INC. | $54.60 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $54.34 | 2021-2023 | Breztri |
| Biohaven Pharmaceuticals, INC. | $43.74 | 2021 | |
| Exact Sciences Corporation | $42.22 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Idorsia Pharmaceuticals US INC | $37.99 | 2022-2023 | Quviviq |
| E.R. Squibb & Sons, L.L.C. | $33.88 | 2021-2024 | Camzyos |
| Amgen INC. | $31.54 | 2021 | |
| Dexcom, INC. | $25.25 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $21.61 | 2021 | |
| Novartis Pharmaceuticals Corporation | $19.34 | 2022 | |
| Allergan, INC. | $18.19 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $17.36 | 2021 | |
| Janssen Pharmaceuticals, INC | $16.93 | 2021 | |
| Rgh Enterprises LLC | $15.99 | 2025 | |
| Orexo US, INC. | $15.38 | 2022 | |
| Alfasigma USA, INC. | $15.22 | 2022 | |
| Phathom Pharmaceuticals, INC. | $15.00 | 2024 | Voquezna |
| Horizon Therapeutics Plc | $14.33 | 2021 | |
| Amarin Pharma, INC. | $13.72 | 2021 | |
| Collegium Pharmaceutical, INC. | $11.82 | 2021 | |
| Indivior INC. | $11.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Kenney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.